BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31608651)

  • 21. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
    Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment.
    Graham SM; Barthold D; Hauber B; Brah AT; Saldarriaga E; Collier AC; Ho RJY; ; Marconi VC; Simoni JM
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26099. PubMed ID: 37439051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-ART Symptoms Were Not the Problem: A Qualitative Study on Adherence to ART in HIV-Infected Patients in a Mozambican Rural Hospital.
    Maixenchs M; Boene H; Anselmo R; Mindu C; Alonso P; Menéndez C; Macete E; Pool R; Letang E; Naniche D; Munguambe K
    PLoS One; 2015; 10(9):e0137336. PubMed ID: 26332680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV-related symptoms.
    Galindo Puerto MJ; Puig J; Pérez-Molina JA; Fuster-Ruiz de Apodaca MJ
    HIV Med; 2024 May; 25(5):565-576. PubMed ID: 38214438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.
    Mantsios A; Murray M; Karver TS; Davis W; Galai N; Kumar P; Swindells S; Bredeek UF; García RR; Antela A; Gomis SC; Bernáldez MP; Czarnogorski M; Hudson K; Walters N; Kerrigan D
    BMC Health Serv Res; 2021 Mar; 21(1):255. PubMed ID: 33743684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes, Beliefs, and Willingness Toward the Use of mHealth Tools for Medication Adherence in the Florida mHealth Adherence Project for People Living With HIV (FL-mAPP): Pilot Questionnaire Study.
    Morano JP; Clauson K; Zhou Z; Escobar-Viera CG; Lieb S; Chen IK; Kirk D; Carter WM; Ruppal M; Cook RL
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e12900. PubMed ID: 31271150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual intervention to support self-management of antiretroviral therapy among people living with HIV.
    Côté J; Godin G; Ramirez-Garcia P; Rouleau G; Bourbonnais A; Guéhéneuc YG; Tremblay C; Otis J
    J Med Internet Res; 2015 Jan; 17(1):e6. PubMed ID: 25563775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies.
    Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
    AIDS Res Ther; 2020 Nov; 17(1):65. PubMed ID: 33168019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intention to initiate antiretroviral therapy (ART) among people living with HIV in China under the scaling-up of ART: the role of healthcare workers' recommendations.
    He Q; Du X; Xu H; Fan L; Maimaitijiang R; Wu Y; Hao C; Li J; Hao Y; Gu J
    BMC Health Serv Res; 2019 May; 19(1):314. PubMed ID: 31096967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia.
    Endebu T; Deksisa A; Dugasa W; Mulu E; Bogale T
    BMC Public Health; 2019 Oct; 19(1):1315. PubMed ID: 31638936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives on ART adherence among Zambian adults living with HIV: insights raised using HIV-related disability frameworks.
    Hanass-Hancock J; Bond V; Solomon P; Cameron C; Maimbolwa M; Menon A; Nixon S
    AIDS Care; 2020 May; 32(5):623-629. PubMed ID: 31416343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronic Health Interventions to Improve Adherence to Antiretroviral Therapy in People Living With HIV: Systematic Review and Meta-Analysis.
    Wang Z; Zhu Y; Cui L; Qu B
    JMIR Mhealth Uhealth; 2019 Oct; 7(10):e14404. PubMed ID: 31621641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study.
    Musheke M; Bond V; Merten S
    AIDS Patient Care STDS; 2013 Apr; 27(4):231-41. PubMed ID: 23530573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US.
    Dubé K; Evans D; Sylla L; Taylor J; Weiner BJ; Skinner A; Thirumurthy H; Tucker JD; Rennie S; Greene SB
    J Virus Erad; 2017 Jan; 3(1):40-50.e21. PubMed ID: 28275457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.
    Dubé K; Eskaf S; Barr L; Palm D; Hogg E; Simoni JM; Sugarman J; Brown B; Sauceda JA; Henley L; Deeks S; Fox L; Gandhi RT; Smith D; Li JZ
    AIDS Res Hum Retroviruses; 2022 Jun; 38(6):510-517. PubMed ID: 35323030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Violence and the perceived risks of taking antiretroviral therapy in US jails and prisons.
    Culbert GJ
    Int J Prison Health; 2014; 10(2):94-110. PubMed ID: 25764073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-serostatus disclosure in the context of free antiretroviral therapy and socio-economic dependency: experiences among women living with HIV in Tanzania.
    Bohle LF; Dilger H; Groß U
    Afr J AIDS Res; 2014 Sep; 13(3):215-27. PubMed ID: 25388976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States.
    Dubé K; Campbell CK; Eskaf S; Sauceda JA; Ndukwe S; Henley L; Persaud D; Deeks SG; Auerbach JD; Saberi P
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):381-399. PubMed ID: 36226414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.